Erlotinib
NDC 0093-7664, Erlotinib, tablet, film coated, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-7664
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091059
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-7664 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERLOTINIB HYDROCHLORIDE150 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-7664-56 | 00093766456 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-7664-56) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5d97f401-4853-4a9a-907d-21e8a4d16088
Use it
Look up 0093-7664 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-7664 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-7664. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.